Global Levetiracetam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212280027 | Category: Pharma & Healthcare | Pages: 90 | Format: PDF | Published Date: February 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Levetiracetam is a drug used to treat epilepsy. It is used for partial seizures, myoclonus or tonic - clonic seizures.
According to our (Global Info Research) latest study, the global Levetiracetam market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Levetiracetam market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Levetiracetam market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Levetiracetam market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Levetiracetam market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Levetiracetam market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Levetiracetam
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Levetiracetam market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB Pharma, GlaxoSmithKline, Eisai Inc, Novartis and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Levetiracetam market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Tablet
    Oral Liquid
    Injection Solution
Market segment by Application
    Myoclonic Treatment
    Tonic-clonic Seizures Treatment
    Others
Major players covered
    UCB Pharma
    GlaxoSmithKline
    Eisai Inc
    Novartis
    Sanofi
    Pfizer
    Zhejiang Jingxin Pharmaceutical
    Salubris Pharmaceuticals
    Chongqing shenghuaxi Pharmaceutical
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levetiracetam product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Levetiracetam, with price, sales, revenue and global market share of Levetiracetam from 2018 to 2023.
Chapter 3, the Levetiracetam competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levetiracetam breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Levetiracetam market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Levetiracetam.
Chapter 14 and 15, to describe Levetiracetam sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Levetiracetam
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Levetiracetam Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Tablet
        1.3.3 Oral Liquid
        1.3.4 Injection Solution
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Levetiracetam Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Myoclonic Treatment
        1.4.3 Tonic-clonic Seizures Treatment
        1.4.4 Others
    1.5 Global Levetiracetam Market Size & Forecast
        1.5.1 Global Levetiracetam Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Levetiracetam Sales Quantity (2018-2029)
        1.5.3 Global Levetiracetam Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 UCB Pharma
        2.1.1 UCB Pharma Details
        2.1.2 UCB Pharma Major Business
        2.1.3 UCB Pharma Levetiracetam Product and Services
        2.1.4 UCB Pharma Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 UCB Pharma Recent Developments/Updates
    2.2 GlaxoSmithKline
        2.2.1 GlaxoSmithKline Details
        2.2.2 GlaxoSmithKline Major Business
        2.2.3 GlaxoSmithKline Levetiracetam Product and Services
        2.2.4 GlaxoSmithKline Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GlaxoSmithKline Recent Developments/Updates
    2.3 Eisai Inc
        2.3.1 Eisai Inc Details
        2.3.2 Eisai Inc Major Business
        2.3.3 Eisai Inc Levetiracetam Product and Services
        2.3.4 Eisai Inc Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eisai Inc Recent Developments/Updates
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Levetiracetam Product and Services
        2.4.4 Novartis Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Novartis Recent Developments/Updates
    2.5 Sanofi
        2.5.1 Sanofi Details
        2.5.2 Sanofi Major Business
        2.5.3 Sanofi Levetiracetam Product and Services
        2.5.4 Sanofi Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Sanofi Recent Developments/Updates
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Levetiracetam Product and Services
        2.6.4 Pfizer Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Pfizer Recent Developments/Updates
    2.7 Zhejiang Jingxin Pharmaceutical
        2.7.1 Zhejiang Jingxin Pharmaceutical Details
        2.7.2 Zhejiang Jingxin Pharmaceutical Major Business
        2.7.3 Zhejiang Jingxin Pharmaceutical Levetiracetam Product and Services
        2.7.4 Zhejiang Jingxin Pharmaceutical Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
    2.8 Salubris Pharmaceuticals
        2.8.1 Salubris Pharmaceuticals Details
        2.8.2 Salubris Pharmaceuticals Major Business
        2.8.3 Salubris Pharmaceuticals Levetiracetam Product and Services
        2.8.4 Salubris Pharmaceuticals Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Salubris Pharmaceuticals Recent Developments/Updates
    2.9 Chongqing shenghuaxi Pharmaceutical
        2.9.1 Chongqing shenghuaxi Pharmaceutical Details
        2.9.2 Chongqing shenghuaxi Pharmaceutical Major Business
        2.9.3 Chongqing shenghuaxi Pharmaceutical Levetiracetam Product and Services
        2.9.4 Chongqing shenghuaxi Pharmaceutical Levetiracetam Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Chongqing shenghuaxi Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Levetiracetam by Manufacturer
    3.1 Global Levetiracetam Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Levetiracetam Revenue by Manufacturer (2018-2023)
    3.3 Global Levetiracetam Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Levetiracetam by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Levetiracetam Manufacturer Market Share in 2022
        3.4.2 Top 6 Levetiracetam Manufacturer Market Share in 2022
    3.5 Levetiracetam Market: Overall Company Footprint Analysis
        3.5.1 Levetiracetam Market: Region Footprint
        3.5.2 Levetiracetam Market: Company Product Type Footprint
        3.5.3 Levetiracetam Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Levetiracetam Market Size by Region
        4.1.1 Global Levetiracetam Sales Quantity by Region (2018-2029)
        4.1.2 Global Levetiracetam Consumption Value by Region (2018-2029)
        4.1.3 Global Levetiracetam Average Price by Region (2018-2029)
    4.2 North America Levetiracetam Consumption Value (2018-2029)
    4.3 Europe Levetiracetam Consumption Value (2018-2029)
    4.4 Asia-Pacific Levetiracetam Consumption Value (2018-2029)
    4.5 South America Levetiracetam Consumption Value (2018-2029)
    4.6 Middle East and Africa Levetiracetam Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Levetiracetam Sales Quantity by Type (2018-2029)
    5.2 Global Levetiracetam Consumption Value by Type (2018-2029)
    5.3 Global Levetiracetam Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Levetiracetam Sales Quantity by Application (2018-2029)
    6.2 Global Levetiracetam Consumption Value by Application (2018-2029)
    6.3 Global Levetiracetam Average Price by Application (2018-2029)
7 North America
    7.1 North America Levetiracetam Sales Quantity by Type (2018-2029)
    7.2 North America Levetiracetam Sales Quantity by Application (2018-2029)
    7.3 North America Levetiracetam Market Size by Country
        7.3.1 North America Levetiracetam Sales Quantity by Country (2018-2029)
        7.3.2 North America Levetiracetam Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Levetiracetam Sales Quantity by Type (2018-2029)
    8.2 Europe Levetiracetam Sales Quantity by Application (2018-2029)
    8.3 Europe Levetiracetam Market Size by Country
        8.3.1 Europe Levetiracetam Sales Quantity by Country (2018-2029)
        8.3.2 Europe Levetiracetam Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Levetiracetam Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Levetiracetam Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Levetiracetam Market Size by Region
        9.3.1 Asia-Pacific Levetiracetam Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Levetiracetam Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Levetiracetam Sales Quantity by Type (2018-2029)
    10.2 South America Levetiracetam Sales Quantity by Application (2018-2029)
    10.3 South America Levetiracetam Market Size by Country
        10.3.1 South America Levetiracetam Sales Quantity by Country (2018-2029)
        10.3.2 South America Levetiracetam Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Levetiracetam Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Levetiracetam Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Levetiracetam Market Size by Country
        11.3.1 Middle East & Africa Levetiracetam Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Levetiracetam Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Levetiracetam Market Drivers
    12.2 Levetiracetam Market Restraints
    12.3 Levetiracetam Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Levetiracetam and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Levetiracetam
    13.3 Levetiracetam Production Process
    13.4 Levetiracetam Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Levetiracetam Typical Distributors
    14.3 Levetiracetam Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Levetiracetam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?